Search our news archive and pharma companies…
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
Biogen
Idec makes bid for Facet Biotech 10:27 AM 9/4/2009
Boston Globe
Biogen Idec Inc submitted a proposal to acquire all outstanding shares of Facet
Biotech Corp.
...
FDA:
Merck's Gardasil Vaccine Effective In Males 9:29 AM 9/4/2009
Wall Street Journal
The US FDA said that Merck & Co's Gardasil vaccine was
effective at preventing genital warts in males. The product has been on the market since 2006.
...
Sucampo
Pulls Application To Sell Constipation Drug In
Europe 7:46 AM 9/4/2009
Wall Street
Journal
Sucampo Pharmaceuticals withdrew its European marketing authorization application (MAA) for
lubiprostone 24 mcg for the indication of Chronic Idiopathic Constipation (CIC) due to its poor position in the
global market.
...
Swine
flu more deadly to adolescents than to younger children
... 3:18 PM 9/3/2009
Los Angeles
Times
The CDC says older children with underlying health problems such as cerebral palsy, muscular
dystrophy, and neurodevelopmental disorders are at the highest risk and should be among the first to be
vaccinated.
...
Powerful
HIV-Blocking Antibodies Raise New Hopes for Vaccine 2:10 PM 9/3/2009
Bloomberg
A new blood screening technique has turned up antibodies with the ability
to neutralize many strains of the AIDS virus. The methods were developed by Monogram Biosciences and Theraclone
Sciences.
...
Merck
eye drug Salutan launched in UK and Spain 11:04 AM 9/3/2009
Forbes
Merck & Co launched the eye pressure drug Saflutan in the UK and Spain.
Merck licensed the drug from Santen Pharmaceutical Co.
...
Vical
gets new patent for flu vaccine, shares jump 8:34 AM 9/3/2009
Reuters
Vical Inc said it received a new US patent covering its
Vaxfectin-formulated DNA vaccines for seasonal and pandemic influenza.
...
Shire
wins US approval for Intuniv drug 6:36 AM 9/3/2009
Reuters
The US FDA approved Shire Plc's selective alpha-2A receptor agonist for the treatment of
attention deficit hyperactivity disorder (ADHD). Intuniv (guanfacine) is expected to be available in US
pharmacies in November.
...
Novartis
Swine Flu Vaccine May Work on Fewer Doses 5:07 AM 9/3/2009
New York Times
Novartis AG said one shot of its swine flu vaccine provided enough
protection as set out by US and European drug regulators. China also approved a swine flu vaccine from Sinovac
saying it too works with one dose.
...
Sepracor
Would Give Dainippon Sumitomo US Sales Force 5:29 PM 9/2/2009
Wall Street Journal
Dainippon Sumitomo Pharma reported interest in buying Sepracor Inc for about
$2.7 billion. DSP is preparing for the US launch of its schizophrenia drug Lurasidone which it plans to file
with the US FDA next year.
...
Roche
Drug Shrinks Tumors in Study 3:39 PM 9/2/2009
Wall Street Journal
The drug GDC-0449 shrank tumors in 18 of 33 patients with an advanced form
of a skin cancer called basal cell carcinoma.
...
US
FDA advisers back Allos' lymphoma drug 2:21 PM 9/2/2009
Reuters
Clinical data for Allos Therapeutics Inc's experimental lymphoma drug Folotyn look
promising for a certain group of patients.
...
FDA
extends review of Endo drug by 3 months 2:09 PM 9/2/2009
Forbes
Endo said the US FDA needs more time to review the application for its long-acting
testosterone undecanoate injection intended to treat hypogonadism. It's sold outside the US as Nedibo.
...
WHO
expert says no doubt H1N1 vaccines will work 8:54 AM 9/2/2009
Reuters
Results obtained through evaluation of H5N1 avian influenza vaccines leave
no doubt that it will be possible to make effective H1N1 pandemic vaccines.
...
FDA
panel wants more data on Genzyme cancer drug 4:34 PM 9/1/2009
The Associated Press
The US FDA's oncology panel voted 9-3 that Genzyme did not
conduct the necessary study to prove its injectable drug Clolar is safe and effective.
...
<- Day Earlier | Today's News
|
